Eva Randárová

Highly effective anti-tumor nanomedicines based on HPMA copolymer conjugates with pirarubicin prepared by controlled RAFT polymerization

Eva Randárová, Hideaki Nakamura, Rayhanul Islam et al. · Acta Biomaterialia · 2020 · 24 citations

Nanomedicine, Hpma Copolymer Conjugates, Engineering +10

Graft copolymers with tunable amphiphilicity tailored for efficient dual drug delivery <i>via</i> encapsulation and pH-sensitive drug conjugation

M Blahová, Eva Randárová, Rafał Konefał et al. · Polymer Chemistry · 2020 · 18 citations

Tunable Amphiphilicity, Engineering, Responsive Polymers +17

HPMA copolymer-antibody constructs in neoplastic treatment: an overview of therapeutics, targeted diagnostics, and drug-free systems

Eva Randárová, Júlia Kudláčová, Tomáš Etrych · Journal of Controlled Release · 2020 · 16 citations

Hpma Copolymer-antibody Constructs, Malignant Disease, Polymer-drug Conjugate +12

Polymer Nanomedicines with Ph-Sensitive Release of Dexamethasone for the Localized Treatment of Inflammation

Alena Libánská, Eva Randárová, Franck Lager et al. · Pharmaceutics · 2020 · 15 citations · Full text

Polymer-ritonavir derivate nanomedicine with pH-sensitive activation possesses potent anti-tumor activity in vivo via inhibition of proteasome and STAT3 signaling

Ladislav Sivák, Vladimír Šubr, Jiřina Kovářová et al. · Journal of Controlled Release · 2021 · 14 citations

Nanomedicine, Tumor Biology, Drug Targeting +9